List of works - Simon Kolstoe

A clinical trial is a success, not a failure, if it does not demonstrate efficacy or does identify safety concerns

Bifunctional crosslinking ligands for transthyretin

scientific article

Call of duty: the ethical imperative to increase the participation of women in UK military research

scientific article published in 2022

Can UK NHS research ethics committees effectively monitor publication and outcome reporting bias?

scientific article published on 25 July 2015

Clinicians wanting to engage with research should join an ethics committee

scientific article published on 07 August 2019

Determining the level of data sharing, and number of publications, from research databases that have been given a favourable opinion by UK research ethics committees

scientific article published on 30 September 2020

Drug targets for amyloidosis

scientific article published on April 2010

Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop

scientific article published on 14 February 2022

Exempting low-risk health and medical research from ethics reviews: comparing Australia, the United Kingdom, the United States and the Netherlands

scientific article published on 28 January 2020

Interaction of serum amyloid P component with hexanoyl bis(D-proline) (CPHPC)

scientific article

Measuring inconsistency in research ethics committee review

scientific article published on 28 November 2017

Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component

scientific article

Perspectives for drug intervention in amyloid diseases.

scientific article

Registration audit of clinical trials given a favourable opinion by UK research ethics committees

scholarly article by Carla Denneny et al published 21 February 2019 in BMJ Open

Research approvals iceberg: helping it melt away

scientific article published on 24 December 2019

Reviewing code consistency is important, but research ethics committees must also make a judgement on scientific justification, methodological approach and competency of the research team

scientific article published on 14 September 2018

Should research ethics committees police reporting bias?

scientific article

Structural basis of ligand specificity in the human pentraxins, C-reactive protein and serum amyloid P component

scientific article

Structure of human porphobilinogen deaminase at 2.8 A: the molecular basis of acute intermittent porphyria

scientific article

Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis

scientific article (publication date: 16 May 2002)

Targeting C-reactive protein for the treatment of cardiovascular disease.

scientific article

Transient expression in HEK 293 cells: an alternative to E. coli for the production of secreted and intracellular mammalian proteins.

scientific article

Trapping of palindromic ligands within native transthyretin prevents amyloid formation

scientific article

Trials are already being prioritised, just not at the institutional level.

scientific article

Virus Control of Cell Metabolism for Replication and Evasion of Host Immune Responses

article

‘The ethics approval took 20 months on a trial which was meant to help terminally ill cancer patients. In the end we had to send the funding back’: a survey of views on human research ethics reviews

scientific article published on 12 January 2021

List of works by Simon Kolstoe

A clinical trial is a success, not a failure, if it does not demonstrate efficacy or does identify safety concerns

Bifunctional crosslinking ligands for transthyretin

Call of duty: the ethical imperative to increase the participation of women in UK military research

Can UK NHS research ethics committees effectively monitor publication and outcome reporting bias?

Clinicians wanting to engage with research should join an ethics committee

Determining the level of data sharing, and number of publications, from research databases that have been given a favourable opinion by UK research ethics committees

Drug targets for amyloidosis

Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop

Exempting low-risk health and medical research from ethics reviews: comparing Australia, the United Kingdom, the United States and the Netherlands

Interaction of serum amyloid P component with hexanoyl bis(D-proline) (CPHPC)

Measuring inconsistency in research ethics committee review

Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component

Perspectives for drug intervention in amyloid diseases.

Registration audit of clinical trials given a favourable opinion by UK research ethics committees

Research approvals iceberg: helping it melt away

Reviewing code consistency is important, but research ethics committees must also make a judgement on scientific justification, methodological approach and competency of the research team

Should research ethics committees police reporting bias?

Structural basis of ligand specificity in the human pentraxins, C-reactive protein and serum amyloid P component

Structure of human porphobilinogen deaminase at 2.8 A: the molecular basis of acute intermittent porphyria

Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis

Targeting C-reactive protein for the treatment of cardiovascular disease.

Transient expression in HEK 293 cells: an alternative to E. coli for the production of secreted and intracellular mammalian proteins.

Trapping of palindromic ligands within native transthyretin prevents amyloid formation

Trials are already being prioritised, just not at the institutional level.

Virus Control of Cell Metabolism for Replication and Evasion of Host Immune Responses

‘The ethics approval took 20 months on a trial which was meant to help terminally ill cancer patients. In the end we had to send the funding back’: a survey of views on human research ethics reviews